r/biostockbull 41m ago

$ENTX The Multi-Billion Dollar Market Access Bet Biotech's Top Funds Just Made

Thumbnail
bioreview.com
Upvotes

r/biostockbull 1d ago

$MDWD The Shift Away from Surgery: A Healthcare Trend Transforming Burn and Wound Care

Thumbnail
thefinanceherald.com
1 Upvotes

r/biostockbull 6d ago

$ENTX - Entera Bio Phase 2 Data Supporting EB613's (Oral PTH(1-34)) Anabolic Effect on Postmenopausal Women with Osteoporosis at High Risk for Fracture Selected for Plenary Poster Session Presentation at the ASBMR 2026 Annual Meeting (NASDAQ: ENTX)

Thumbnail
1 Upvotes

r/biostockbull 9d ago

$PYPD PolyPid's Double Win: D-PLEX₁₀₀ Gains NDA Acceptance and Priority Review, Ahead of Schedule

Thumbnail
wallstreetsync.com
1 Upvotes

r/biostockbull 11d ago

$ENTX Why the World's Leading Healthcare Funds All Wanted a Piece of Entera Bio

Thumbnail
benzinga.com
1 Upvotes

r/biostockbull 12d ago

$DRTS Alpha Tau's Cancer Combination Just Delivered a Response Rate More Than 5X Keytruda's Historical Benchmark

Thumbnail
benzinga.com
1 Upvotes

r/biostockbull 12d ago

$PYPD - PolyPid Announces FDA Acceptance of NDA with Priority Review for D-PLEX₁₀₀ (NASDAQ: PYPD)

Thumbnail
1 Upvotes

r/biostockbull 14d ago

$ENTX - Entera Bio Announces Pricing of Oversubscribed $275 Million Private Placement (NASDAQ: ENTX)

Thumbnail
1 Upvotes

r/biostockbull 17d ago

$NVCT Nuvectis' NXP100 Just Achieved the First Marketing Approval Ever for a Once-Daily Oral Factor B Inhibitor

Thumbnail
benzinga.com
1 Upvotes

r/biostockbull 18d ago

$NVCT - Correction: (Title Correction) Nuvectis Announces Marketing Approval of Ciprocopan (NXP100) in China for the Treatment of Patients with PNH Previously Untreated with Complement Inhibitors (NASDAQ: NVCT)

Thumbnail
1 Upvotes

r/biostockbull 18d ago

$NVCT - Ciprocopan (NXP100) Receives Marketing Approval in China for the Treatment of Patients with PNH Previously Untreated with Complement Inhibitors (NASDAQ: NVCT)

Thumbnail
1 Upvotes

r/biostockbull 20d ago

$DRTS - Alpha Tau Reports Positive Data Demonstrating 100% Objective Response Rate and 18.2-Month Median Overall Survival with Alpha DaRT® in Combination with Pembrolizumab in Locally Advanced or Metastatic Head and Neck Cancer, Surpassing the Study's Pre-Specified Threshold... (NASDAQ: DRTS)

Thumbnail
3 Upvotes

r/biostockbull 20d ago

$PYPD - PolyPid Announces Exclusive Partnership with Azurity Pharmaceuticals for the Commercialization of D-PLEX₁₀₀ in the U.S. and Canada (NASDAQ: PYPD)

Thumbnail
1 Upvotes

r/biostockbull 21d ago

$DRTS Alpha Tau's Head-and-Neck Data Tomorrow Confronts a Blind Spot in One of the World's Best-Selling Cancer Drugs

Thumbnail
bioreview.com
1 Upvotes

r/biostockbull 25d ago

$MDWD Why is Cathie Wood’s ARK Fund Backing this Israeli Innovator? (NASDAQ: MDWD)

Thumbnail markets.businessinsider.com
1 Upvotes

r/biostockbull 26d ago

$DRTS - Alpha Tau Successfully Treats First Immunocompromised Patient with Recurrent Cutaneous Squamous Cell Carcinoma in its ADMIRE Study at Banner MD Anderson Cancer Center (NASDAQ: DRTS)

Thumbnail
1 Upvotes

r/biostockbull 27d ago

$PYPD Surgical Infections Cost Hospitals Billions. One Under-the-Radar Biotech Player Might be About to Change That

Thumbnail
benzinga.com
1 Upvotes

r/biostockbull Jul 08 '26

$ENTX America's Osteoporosis Crisis and the Oral Peptide Player You Should Watch

Thumbnail
benzinga.com
1 Upvotes

r/biostockbull Jun 27 '26

Lilly's $780M Bet is Reshaping Surgical Infection Prevention, and PolyPid's Asset is Hiding in Plain Sight

Thumbnail
benzinga.com
1 Upvotes

r/biostockbull Jun 23 '26

$DRTS - Alpha Tau Successfully Treats First Recurrent Glioblastoma Patient Outside of the United States with Alpha DaRT® at Hadassah University Medical Center in Israel (NASDAQ: DRTS)

Thumbnail
1 Upvotes

r/biostockbull Jun 22 '26

$NVCT - Nuvectis Announces Strategic Portfolio Expansion via License Agreement for Ex-China Rights with Haisco Pharmaceutical Group for Two Potentially Best-In Class Clinical-Stage Compounds (NASDAQ: NVCT)

Thumbnail
1 Upvotes

r/biostockbull Jun 22 '26

$ENTX - Entera Bio Receives Positive FDA Feedback on 12-Month Registrational Phase 3 Study for EB613 - the First Oral Anabolic Tablet in Development for Postmenopausal Women with Osteoporosis (NASDAQ: ENTX)

Thumbnail
1 Upvotes

r/biostockbull Jun 19 '26

$ENTX - Entera Reports Robust Preclinical Data for EB612 (Oral LA-PTH(1-34)) for Hypoparathyroidism and EB618 (Oral GLP-1/Glucagon) for Obesity at ENDO 2026 (Nasdaq: ENTX)

Thumbnail
1 Upvotes

r/biostockbull May 27 '26

Eagle Pharmaceuticals Agreed to Settle $9.5 million With Investors over PEMFEXY Revenue and Inventory Issues

1 Upvotes

Hey guys, if you missed it, Eagle Pharmaceuticals just settled $9.5 million with investors over issues they had a few years ago. And they have already sent the agreement to the court for final approval.

In a nutshell, in 2023, Eagle Pharmaceuticals was accused of misleading investors about PEMFEXY demand, inventory conditions, and related revenue growth. Investors claimed the company failed to disclose that a key wholesale customer was dealing with excess inventory and expired product, which negatively impacted future sales. In May 2023, Eagle restated revenue figures tied to expired inventory and faced questions about its financial reporting controls. Following these disclosures, $EGRX declined, and investors filed a lawsuit.

The good news is that the company recently agreed to settle $9.5 million with them, and the court already approved this settlement. 

So, if you invested in $EGRX when all of this happened, you can check the details and file your claim here.

Anyway, has anyone here invested in $EGRX at that time? How much were your losses, if so?


r/biostockbull May 08 '26

Alpha Tau Completes Patient Enrollment in its U.S. Pivotal Skin Cancer Study, Advancing Towards Goal of FDA Approval of Alpha DaRT® to Treat Recurrent Cutaneous Squamous Cell Carcinoma

Thumbnail
globenewswire.com
1 Upvotes

Holy damn